<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04096339</url>
  </required_header>
  <id_info>
    <org_study_id>BIO-2018-0629</org_study_id>
    <nct_id>NCT04096339</nct_id>
  </id_info>
  <brief_title>Reduction in Sedation: Colonoscopy vs Esophagoduodenoscopy First</brief_title>
  <acronym>RECoVER</acronym>
  <official_title>RECoVER: Reduction in Sedation: Colonoscopy vs Esophagoduodenoscopy First</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American University of Beirut Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American University of Beirut Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to compare the effect of different procedural sequences on
      the time to recovery and the propofol sedation requirements in patients undergoing
      bidirectional endoscopy with sedation.

      The two sequences are:

        -  Colonoscopy followed by Esophagogastroduodenoscopy (EGD)

        -  EGD followed by Colonoscopy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      120 patients will be asked to participate in the trial. The subject will undergo both
      procedures in the order assigned by the randomization sheet. During the procedure, the
      endoscopist and anesthesiologists will collect data including but not limited to vital signs
      (heart rate, blood oxygen level, blood pressure) and level of sedation through the Bispectral
      Index Monitor (BIS). After completing the procedures, the patient will be approached in the
      recovery room by the study coordinator who will administer the Modified Post Anesthesia
      Discharge Scoring System (M-PADSS) scale every 5 minutes until a score of 9 or higher is
      obtained on two consecutive attempts. 24 hours following the procedure, the study coordinator
      will call the patient in order to assess the patient's cognitive function and drowsiness
      after they were discharged from the endoscopy unit.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 3, 2019</start_date>
  <completion_date type="Anticipated">January 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to discharge</measure>
    <time_frame>1 hour</time_frame>
    <description>Time from end of procedures to patient discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Propofol dose</measure>
    <time_frame>1 hour</time_frame>
    <description>Propofol sedation requirements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depth of anesthesia</measure>
    <time_frame>1 hour</time_frame>
    <description>Bispectral Index (BIS) tracking of depth of anesthesia throughout the two procedures. BIS is a single dimensionless number generated by EEG analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive impairment</measure>
    <time_frame>24 hours</time_frame>
    <description>An assessment of cognitive impairment after the subject emerges from sedation, using the Modified Post Anesthesia Discharge System (M-PADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events during sedation</measure>
    <time_frame>1 hour</time_frame>
    <description>apnea, desaturations, hypotension, bradycardia and other hemodynamical disturbances during sedation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anesthesia, Recovery</condition>
  <arm_group>
    <arm_group_label>EGD followed by Colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomized to group Esophagogastroduodenoscopy followed by Colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colonoscopy followed by EGD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomized to group Colonoscopy followed by Esophagogastroduodenoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Colonoscopy followed by EGD</intervention_name>
    <description>Colonoscopy is done first followed by EGD</description>
    <arm_group_label>Colonoscopy followed by EGD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EGD followed by Colonoscopy</intervention_name>
    <description>Esophagoduodenoscopy (EGD) is done first followed by Colonoscopy</description>
    <arm_group_label>EGD followed by Colonoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age above 18

          -  Scheduled EGD and colonoscopy on the same day

          -  Scheduled to Anaesthesiologist administered sedation during the procedure

        Exclusion Criteria:

          -  Age below 18

          -  Known allergy or adverse reaction to Propofol, Midazolam or opioid medication (ex:
             fentanyl)

          -  Medical contraindication to Anaesthesia

          -  Sleep apnea

          -  American Society of Anesthesiologists classification (ASA) &gt;3

          -  Inpatient status

          -  Pregnant or lactating women

          -  Known cirrhosis

          -  Chronic Kidney Disease (stage 4 or 5)

          -  Known psychological disorder

          -  Known cognitive dysfunction

          -  Significant gastroparesis

          -  Gastric outlet obstruction

          -  Ileus

          -  Known or suspected bowel obstruction or perforation

          -  Having a stoma

          -  Compromised swallowing reflex or mental status

          -  Prior colon resection or gastric surgery

          -  Age above 75 years

          -  Chronic use of more than 1 psychoactive drug (Benzodiazepines, Tricyclic
             antidepressants, antipsychotics, selective serotonin receptor inhibitors, serotonin
             norepinephrine receptor inhibitors, Monoamine oxidase inhibitor)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ala I Sharara, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>American University of Beirut Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ala I Sharara, MD</last_name>
    <phone>+961-1-350000</phone>
    <phone_ext>5345</phone_ext>
    <email>as08@aub.edu.lb</email>
  </overall_contact>
  <location>
    <facility>
      <name>American University of Beirut - Medical Center</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ala' I. Sharara, MD</last_name>
      <phone>009611350000</phone>
      <phone_ext>5345</phone_ext>
      <email>as08@aub.edu.lb</email>
    </contact>
    <investigator>
      <last_name>Ala' I Sharara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 11, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>September 18, 2019</last_update_submitted>
  <last_update_submitted_qc>September 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>American University of Beirut Medical Center</investigator_affiliation>
    <investigator_full_name>Ala'a Sharara, MD</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>EGD</keyword>
  <keyword>Sedation</keyword>
  <keyword>procedural sequence</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

